Investors with an eye for opportunity in the healthcare sector might find Soleno Therapeutics, Inc. (NASDAQ: SLNO) an intriguing prospect. This clinical-stage biopharmaceutical company, with a market capitalization of $2.56..
Bausch + Lomb Corporation (BLCO), headquartered in Vaughan, Canada, stands as a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization..
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is a key player in the biopharmaceutical sector, focusing on rare neuroendocrine diseases. With a market capitalization of $7.34 billion, this Boston-based company is an..
iRhythm Technologies, Inc. (NASDAQ: IRTC) is capturing the attention of investors in the healthcare sector, specifically within the medical devices industry. With its significant market cap of $5.69 billion, iRhythm..
Integer Holdings Corporation (NYSE: ITGR), a key player in the healthcare sector, is attracting investor attention with a potential upside of 8.48%, as indicated by its average target price. The..
Incyte Corporation (NASDAQ: INCY), a prominent player in the biotechnology sector, stands out with its robust pipeline and expansive revenue growth, capturing the attention of investors looking for promising opportunities..
BrightSpring Health Services, Inc. (NASDAQ: BTSG) is making waves in the healthcare sector, specifically within the health information services industry. With a substantial market cap of $6.81 billion, the company..
Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a leading name in the biopharmaceutical realm, is renowned for its pioneering work in RNA-targeted therapies and gene therapies for rare diseases like Duchenne muscular..
BridgeBio Pharma, Inc. (NASDAQ: BBIO), a trailblazer in the biotechnology sector, is capturing investor attention with its remarkable financial and operational metrics. With a market capitalization of $14.61 billion, this..
Elanco Animal Health Incorporated (NYSE: ELAN) stands as a prominent player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. Headquartered in Greenfield, Indiana, Elanco is..
Avidity Biosciences, Inc. (NASDAQ: RNA), a cutting-edge biopharmaceutical firm, is stirring interest in the biotechnology sector with its innovative approach to RNA therapeutics. With a market capitalization of $10.87 billion,..
Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a prominent player in the biotechnology sector, has been turning heads with its promising strides in developing therapeutics for metabolic dysfunction-associated steatohepatitis (MASH). With a..
For investors eyeing opportunities in the healthcare sector, Option Care Health, Inc. (NASDAQ: OPCH) presents a compelling case with its robust growth potential and strong market position. This medical care..
Tenet Healthcare Corporation (NYSE: THC) presents a compelling investment opportunity in the healthcare sector, boasting a significant market capitalization of $17.72 billion. As a leading player in the medical care..
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), a prominent player in the biotechnology sector, offers investors an intriguing opportunity with its focus on RNA-targeted medicines. With a market capitalization of $12.95 billion,..
Telix Pharmaceuticals Limited (ASX: TLX), an Australian biopharmaceutical company specializing in radiopharmaceuticals for therapeutic and diagnostic applications, is capturing the attention of investors with its substantial potential upside of 167.02%...
Alkermes plc (NASDAQ: ALKS), an innovative force in the healthcare sector, stands out in the competitive landscape of specialty and generic drug manufacturing. Headquartered in Dublin, Ireland, this biopharmaceutical company..
ADMA Biologics Inc (NASDAQ: ADMA) is carving out a niche in the healthcare sector with its focus on developing and marketing specialty plasma-derived biologics. As a prominent player in the..
Royalty Pharma plc (NASDAQ: RPRX), a key player in the biotechnology sector, offers a unique investment proposition through its robust royalty portfolio. With a market capitalization of $22.87 billion, Royalty..
Becton, Dickinson and Company (NYSE: BDX) stands as a stalwart in the healthcare sector, a critical player in the Medical Instruments & Supplies industry. With a robust market capitalization of..
